27 June 2016 : Case report
Challenging differential diagnosis, Unusual setting of medical care, Rare diseaseMohsen PourmortezaBEF, Fady TawadrosBEF, Gilbert BaderBF, Mohamed Al-TarawnehBF, Emilie CookBD, Wael ShamsBF, Mark YoungF
Am J Case Rep 2016; 17:434-438
BACKGROUND: Pyoderma gangrenosum is a rare, ulcerative cutaneous condition that was first described by Brocq in 1916. This diagnosis is quite challenging as the histopathological findings are nonspecific. Pyoderma gangrenosum is usually associated with inflammatory bowel disease, leukemia, and hepatitis C. We describe a rare clinical case of a patient with hepatitis C (HCV), mixed cryoglubinemia, and pyoderma gangrenosum, which was successfully treated with prednisone in combination with the new antiviral medication ledipasvir/sofosbuvir.
CASE REPORT: A 68-year-old male with a history of untreated HCV presented to the clinic with a left lower extremity ulcer that had progressively worsened over 4 days after the patient sustained a minor trauma to the left lower extremity. Examination revealed a 2×3 cm purulent ulcer with an erythematous rim on medial aspect of his left lower leg. HCV viral load and genotype analysis revealed genotype 1A with polymerase chain reaction (PCR) showing viral counts of 9,506,048 and cryoglobulinemia. With a worsening and enlarging erythematous ulcer and failure of IV antibiotic therapy, the patient underwent skin biopsy, which showed acanthotic epidermis with superficial and deep perivascular lymphoplasmacytic dermatitis admixed with mild neutrophilic infiltrate. The patient was subsequently started on ledipasvir/sofosbuvir and prednisone with a high suspicion of pyoderma gangrenosum. At one-month follow-up at the hepatology clinic, the patient demonstrated a near resolution of the lower extremity ulcer with undetectable viral load.
CONCLUSIONS: Pyoderma gangrenosum is an inflammatory process of unknown etiology, and establishing the correct diagnosis can be a difficult task. For this reason it is prudent for clinicians to consider Pyoderma gangrenosum in their differential diagnosis, especially in the setting of a nonhealing surgical wound or skin infection.
Keywords: Anti-Inflammatory Agents - therapeutic use, Antiviral Agents - therapeutic use, Benzimidazoles - therapeutic use, Cryoglobulinemia - drug therapy, Fluorenes - therapeutic use, Hepatitis C, Chronic - drug therapy, Prednisone - therapeutic use, Pyoderma Gangrenosum - drug therapy, Uridine Monophosphate - therapeutic use, Viral Load
09 Jan 2024 : Case reportNeurotrophic Keratopathy in Marfan Syndrome Patient After Micropulse Transscleral Cyclophotocoagulation: A ...
Am J Case Rep In Press; DOI: 10.12659/AJCR.942538
03 Feb 2024 : Case reportDefinitive Closure Using an Ovine Reinforced Tissue Matrix in Contaminated Penetrating Abdominal Trauma
Am J Case Rep In Press; DOI: 10.12659/AJCR.943188
10 Jan 2024 : Case reportHerpes Simplex Keratitis as a Complication of Pterygium Surgery
Am J Case Rep In Press; DOI: 10.12659/AJCR.942401
Most Viewed Current Articles
10 Jan 2022 : Case reportA Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case reportAtlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19
Am J Case Rep 2022; 23:e936128
05 Mar 2022 : Case reportAcute Limb Ischemia After Self-Injection of Crushed Morphine Tablets into the Radial Artery: Role of Infrar...
Am J Case Rep 2022; 23:e935336